Latest filing published 03 Aug 2026 for Ares Management Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Judy D. Olian across 3 companies, led by UNITED THERAPEUTICS Corp, Ares Management Corp and Mattel Inc /DE/. The record holds 39 filings, for trades running from 26 June 2021 to 30 July 2026.
On the open market, the record shows 1 purchase worth €51k and 11 sales worth €3.2M. Netting one side against the other leaves €3.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants and 16 option exercises. 2026 to date brings 1 purchase and 4 sales.
On 3 August 2026 came the latest disclosure, a share grant in Ares Management Corp. The clock since the last published purchase (24 February 2026) now reads 236 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations